TPCN2 and neoplasm: The controversy about whether TPC2/Ca2+signaling in metastatic cancer promotes or hampers metastatic traits—such as tumour cell adhesion, motility, invasion and progression—might reflect TPC2 having differential roles in different types or stages of cancer.